CITIC Capital has increased its stake in Harbin Pharmaceutical Group to 60.86%, becoming the controlling shareholder of the Chinese state-backed business in which it has been an investor since 2005.
Harbin Pharmaceutical was the GP's first state-owned enterprise (SOE) restructuring deal. In 2005, it partnered with Warburg Pincus and local PE firm Heilongjiang Chenergy Hit High-Tech Venture Capital...
Space Cycle, a boutique fitness studio chain operating in mainland China and Taiwan, has raised a RMB100 million ($15.6 million) Series B round of funding led by Alibaba Taiwan Entrepreneurs Fund.
Creador is targeting $500 million for its fourth Southeast Asia and India-focused fund. The private equity firm closed its previous vehicle at $415 million in late 2016.
SBI Investment, the VC arm of Japan’s SBI Holdings, has launched a JPY50 billion ($450 million) fund that will focus on artificial intelligence (AI) and blockchain technology.
Singapore’s Temasek Holdings has led a Series C round of undisclosed size for Rokid, a Chinese artificial intelligence (AI) developer focused on home automation devices.